Not Worried About SP... Honestly, if everyone believes in the science, then this pps is a gift. I'm certainly not one of those highly experienced/technical traders like some of you, but it seems to me the greatest opportunity for maximal wealth creation is if this company can survive independently for as LONG as possible. You can ultimately fully own/license your technology, etc....but a premature buyout or partnership simply reduces prematurely your maximum future reward imo.
People may scoff at the idea of future financing &/or a share consolidation & their dilutive impacts, but I certainly wouldn't scoff at the above if done properly...I guess that's a big IF in many investors' minds. But if we were to stay independent, I'd be interested in hearing some of your thoughts about the possibility of a rights offering (non-transferable) for future financing of a second indication? I believe if we can stay independent & prove our superior efficacy in a second or "hard-to-reach" indication, our value "takes off" as we are now seen as a true threat in the solid tumor market (deep or superficial/luminal).
Obviously, I'm not sure mgmt would even offer such a gesture of consideration to its shareholder base...they should. Such an offering would certainly offset any dilutive impact of a future share consolidation, if needed. IMO, if we can get FDA approved for NMIBC, we may not immediately qualify for an NAS listing, but ultimately, I don't think it would require more than a 1-for-2 consolidation, during which time you have protected your wealth & likely created an opportunity for A LOT more vs selling out prematurely. Call me an optimist or maybe just a dreamer.